… ProQR to Present at the 2015 Leerink Global Healthcare … be accessible from the "Investor Relations" section of ProQR's website ( www.proqr.com ). The archived webcast will be available for …
LEIDEN, the Netherlands, March 01, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases including cystic fibrosis (CF), Leber's congenital
… ProQR Announces Financial Results for the Second Quarter of … Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … progress towards accomplishing the goals set out in ProQR’s Vision 2023 strategy, which includes starting the …
… ProQR Announces Virtual Presentations at American Academy of … & CAMBRIDGE, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … Academy of Ophthalmology (AAO) held November 13-15, 2020. ProQR’s presentations Presentation title: Phase 1b/2 trial …
… ProQR to Present at the RBC Capital Markets Healthcare … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
… ProQR to Present at the JMP Securities Life Sciences … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
… ProQR Announces Expert Perspectives Call on LCA10 and … & CAMBRIDGE, Mass., July 13, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … presentation by Aniz Girach, MD, Chief Medical Officer of ProQR Therapeutics. Dr. Girach will then discuss the …